Closing Remarks is the kind of topic that looks straightforward until it collides with the speed, ambiguity, and competing demands of case conceptualization, intervention design, staff training, and literature-informed problem solving. In Closing Remarks, for this course, the practical stakes show up in stronger conceptual consistency and better translational decision making, not in abstract discussion alone.
Provider: BehaviorLive — via AVBCC
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →Joe DePinto and Bob Preti will be hosting the closing remarks.
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
Joe has spent the past 30 years focused on bringing life-saving specialty drugs to market, helping patients with complex diseases to access advanced care, and developing future leaders in the healthcare industry. Joe is a passionate leader with a commitment to mentorship and building strong, diverse teams. Joe was the first male National Board member of the Healthcare Businesswomen’s Association.Joe’s experience includes operations globally for multiple biotech, pharma, distribution, professional services, and technology companies. He is recognized for consistently delivering multi-million-dollar revenue gains in highly competitive marketplaces. His core leadership competencies include leading all aspects of strategy, drug development, investor relations, and commercialization with multiple global launches. Most recently, Joe served as Chief Commercial Officer at Vineti, a venture-based technology start-up focused on industrializing the value chain for personalized therapies. His past roles have also included leadership positions at top pharmaceutical companies, Johnson & Johnson and Lilly. Joe also previously served as the President of Cardinal Health Specialty Solutions, EVP Chief Commercial Officer at Sunesis Pharmaceuticals, EVP Global Commercial Operations at Dendreon, VP Global Commercial Operations at ImClone, and VP at Abraxis Oncology.Joe has been published in multiple publications on cell and gene therapy, including Cell & Gene Therapy Insights and PharmaVoice.Joe’s academic credentials include a BS in Marketing and an MBA, with an emphasis on Pharmaceutical/Chemical Studies.
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.